Due to its key role in regulating the cellular antioxidant and anti-inflammatory responses, upregulation of Nrf2 is a common therapeutic target for neuropsychiatric disorders such as major depression, bipolar disorder, and schizophrenia [35]. Here, NFE2L2 is linked to schizophrenia.